Compare Infosys Limited (INFY) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Infosys Limited vs Koninklijke Philips NV — how do they compare? Infosys Limited trades at $10.73 (market cap $41.74B), while Koninklijke Philips NV trades at $24.24 (market cap $23.52B). The key difference: Infosys Limited is the larger of the two by market cap, and Infosys Limited pays the higher dividend (4.89%). Which is the better fit depends on your goals — on Pluang, investors hold Infosys Limited for 27 Days and Koninklijke Philips NV for 84 Days on average.
| INFY | PHG | |
|---|---|---|
Market Cap | $41.74B | $23.52B |
Volume | 31,354,285 | 1,635,069 |
Sector | Technology | Health |
52-Week High | $20.22 | $32.91 |
52-Week Low | $10.49 | $23.81 |
Typical Hold Time | 27 Days | 84 Days |
Enterprise Value | $39.48B | $29.87B |
Dividend Yield | 4.89% | 4.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INFY trades at $10.70, up 1.42% today, with a bearish technical signal from moving averages. The company reported revenue of $19.28B in 2025, with a net income margin of 16.37%. Recent news highlights strategic AI collaborations, including with Columbia University and ABN Amro. Analyst consensus is a 'Hold' with a $11.48 price target, indicating modest upside potential from current levels.
The outlook is mixed: strong profitability and recent earnings beats support the stock, but a projected negative net cash flow in 2026 and bearish technical indicators pose risks. Investor sentiment is cautious amid weak Western IT spending concerns, though institutional holdings show confidence. Key risks include competitive pressures and macroeconomic headwinds affecting IT services demand.
PHG trades at $24.30, up 0.87% with a bearish technical signal despite three consecutive quarterly earnings beats. The company shows improving fundamentals with net income turning positive at $895 million in 2025 after previous losses, supported by strong operational cash flow of $1.17 billion. Recent developments include new product launches in healthcare technology and a $33.7 million ARPA-H award for AI-enabled stroke care.
While analyst consensus leans Hold (63.64%), the improving profitability trajectory and reasonable valuation (P/E 18.94) present opportunity, though technical weakness and competitive healthcare market risks require monitoring. The stock faces resistance near $25 with support at $24, with institutional ownership showing mixed signals through recent acquisitions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Infosys Limited
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
